Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ana Gleisner

Concepts (344)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatectomy
59
2026
274
8.490
 Why?
Liver Neoplasms
53
2026
776
6.890
 Why?
Carcinoma, Hepatocellular
37
2026
372
6.250
 Why?
Pancreatic Neoplasms
25
2025
928
3.840
 Why?
Cholangiocarcinoma
19
2026
108
3.810
 Why?
Bile Duct Neoplasms
18
2026
131
3.490
 Why?
Adenocarcinoma
25
2024
925
3.310
 Why?
Laparoscopy
10
2026
481
3.010
 Why?
Neoplasm Recurrence, Local
26
2026
1149
2.760
 Why?
Sentinel Lymph Node
8
2022
49
2.630
 Why?
Minimally Invasive Surgical Procedures
8
2026
189
2.420
 Why?
Melanoma
12
2022
759
2.370
 Why?
Sentinel Lymph Node Biopsy
12
2025
117
2.300
 Why?
Skin Neoplasms
12
2022
849
2.270
 Why?
Lymph Node Excision
13
2026
173
2.190
 Why?
Pancreaticoduodenectomy
11
2024
137
2.130
 Why?
Postoperative Complications
26
2026
2970
1.950
 Why?
Tumor Burden
18
2026
325
1.930
 Why?
Pancreatectomy
8
2025
289
1.720
 Why?
Robotic Surgical Procedures
4
2026
185
1.510
 Why?
Survival Rate
41
2026
2090
1.510
 Why?
Retrospective Studies
97
2026
17291
1.460
 Why?
Prognosis
49
2026
4316
1.350
 Why?
Aged
98
2026
26153
1.300
 Why?
Lymph Nodes
10
2026
503
1.270
 Why?
Colorectal Neoplasms
10
2026
866
1.220
 Why?
Bilirubin
6
2025
99
1.130
 Why?
Middle Aged
106
2026
36215
1.100
 Why?
Databases, Factual
20
2025
1490
1.100
 Why?
Breast Neoplasms
6
2025
2382
1.100
 Why?
Lymphatic Metastasis
17
2026
331
1.040
 Why?
Liver Transplantation
12
2025
826
0.950
 Why?
Esophageal Neoplasms
8
2025
348
0.930
 Why?
Esophagectomy
4
2021
135
0.850
 Why?
Female
118
2026
78845
0.850
 Why?
Risk Assessment
22
2026
3747
0.840
 Why?
Humans
149
2026
145475
0.840
 Why?
Male
113
2026
72843
0.810
 Why?
Serum Albumin
6
2025
147
0.780
 Why?
Conversion to Open Surgery
2
2020
22
0.770
 Why?
Thrombelastography
1
2024
192
0.760
 Why?
Neoplasm Staging
14
2026
1471
0.750
 Why?
alpha-Fetoproteins
5
2025
42
0.750
 Why?
Nomograms
2
2022
59
0.750
 Why?
Follow-Up Studies
26
2026
5423
0.720
 Why?
Carcinoma, Pancreatic Ductal
5
2023
293
0.690
 Why?
Rectal Neoplasms
5
2023
159
0.660
 Why?
Machine Learning
4
2026
587
0.580
 Why?
Colonic Neoplasms
3
2024
257
0.570
 Why?
Treatment Outcome
30
2026
11772
0.530
 Why?
Head and Neck Neoplasms
6
2019
561
0.510
 Why?
Quality of Life
2
2019
3204
0.500
 Why?
Metastasectomy
3
2024
19
0.490
 Why?
CA-19-9 Antigen
3
2026
34
0.490
 Why?
Peritoneal Neoplasms
3
2024
104
0.470
 Why?
Neoadjuvant Therapy
11
2023
465
0.460
 Why?
Colectomy
3
2013
106
0.450
 Why?
Hepatic Artery
2
2026
53
0.450
 Why?
Aged, 80 and over
20
2025
8333
0.440
 Why?
Predictive Value of Tests
9
2025
2121
0.430
 Why?
Liver Failure
3
2009
83
0.420
 Why?
Disease-Free Survival
11
2025
767
0.390
 Why?
Axilla
3
2023
51
0.390
 Why?
Length of Stay
8
2026
1349
0.380
 Why?
Stomach Neoplasms
2
2024
128
0.370
 Why?
Risk Factors
20
2025
10885
0.370
 Why?
Cytoreduction Surgical Procedures
3
2024
69
0.370
 Why?
Blood Loss, Surgical
4
2026
113
0.370
 Why?
Decision Making
1
2019
977
0.350
 Why?
Propensity Score
4
2024
377
0.340
 Why?
Ampulla of Vater
2
2024
40
0.330
 Why?
Margins of Excision
5
2025
50
0.320
 Why?
Decision Support Techniques
2
2025
477
0.310
 Why?
ROC Curve
5
2025
617
0.300
 Why?
Adult
39
2026
40777
0.300
 Why?
United States
19
2025
16098
0.300
 Why?
Benchmarking
2
2021
191
0.290
 Why?
Liver Cirrhosis
5
2025
287
0.290
 Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
14
0.290
 Why?
Preoperative Care
5
2025
380
0.290
 Why?
Serum Albumin, Human
2
2025
7
0.290
 Why?
Neuroendocrine Tumors
2
2023
119
0.280
 Why?
Gallbladder Neoplasms
2
2024
20
0.280
 Why?
Time Factors
10
2025
7123
0.260
 Why?
Quality Indicators, Health Care
3
2026
336
0.250
 Why?
Mastectomy, Segmental
2
2017
107
0.250
 Why?
Lymphocytes
2
2025
376
0.240
 Why?
Inflammation
4
2025
2878
0.240
 Why?
Proportional Hazards Models
5
2025
1327
0.240
 Why?
Survival Analysis
7
2024
1374
0.230
 Why?
Time-to-Treatment
2
2025
251
0.230
 Why?
Catheter Ablation
2
2008
355
0.230
 Why?
Abdominal Neoplasms
1
2025
47
0.230
 Why?
Vena Cava, Inferior
1
2026
83
0.230
 Why?
Infusions, Intra-Arterial
1
2025
61
0.220
 Why?
gamma-Glutamyltransferase
1
2025
42
0.220
 Why?
Hyperglycemia
2
2020
379
0.220
 Why?
Neoplasm Invasiveness
6
2026
506
0.220
 Why?
Medical Futility
1
2025
32
0.220
 Why?
Portal Vein
1
2026
117
0.210
 Why?
Anastomotic Leak
1
2024
45
0.210
 Why?
Abdomen, Acute
1
2004
21
0.210
 Why?
Age Factors
5
2025
3342
0.210
 Why?
Cohort Studies
10
2023
6013
0.200
 Why?
Bacterial Infections
3
2006
246
0.200
 Why?
End Stage Liver Disease
1
2025
95
0.200
 Why?
Lymphopenia
1
2024
62
0.200
 Why?
Biomarkers, Tumor
3
2025
1321
0.200
 Why?
Chemotherapy, Adjuvant
6
2025
423
0.200
 Why?
Odds Ratio
4
2019
1082
0.200
 Why?
Operative Time
4
2026
181
0.200
 Why?
Combined Modality Therapy
6
2024
1266
0.190
 Why?
Cannabinoids
1
2025
184
0.190
 Why?
Kaplan-Meier Estimate
4
2025
969
0.190
 Why?
Practice Guidelines as Topic
2
2024
1581
0.190
 Why?
Multilocus Sequence Typing
1
2022
16
0.190
 Why?
C-Reactive Protein
1
2025
422
0.190
 Why?
SEER Program
2
2014
229
0.190
 Why?
Lymphoscintigraphy
2
2019
10
0.190
 Why?
Sunburn
1
2002
26
0.180
 Why?
Surgical Oncology
1
2022
30
0.180
 Why?
Sunscreening Agents
1
2002
25
0.180
 Why?
Nevus, Pigmented
1
2002
35
0.180
 Why?
Pelvic Exenteration
2
2019
12
0.180
 Why?
Patient Selection
2
2025
738
0.180
 Why?
Lung Neoplasms
3
2023
2664
0.180
 Why?
Prospective Studies
9
2025
8057
0.180
 Why?
Killer Cells, Natural
1
2025
480
0.170
 Why?
Klatskin Tumor
1
2021
18
0.170
 Why?
Mastectomy
1
2023
184
0.170
 Why?
Anesthetics, Inhalation
1
2021
52
0.160
 Why?
Chemoradiotherapy
4
2023
239
0.160
 Why?
Body Mass Index
3
2025
2445
0.160
 Why?
Propofol
1
2021
85
0.160
 Why?
Hyperthermia, Induced
2
2020
120
0.160
 Why?
Organ Preservation
4
2023
125
0.150
 Why?
Cancer Survivors
1
2025
337
0.150
 Why?
Scalp
1
2019
38
0.150
 Why?
Regression Analysis
2
2019
1001
0.150
 Why?
Artificial Intelligence
1
2024
381
0.150
 Why?
Reoperation
3
2017
633
0.140
 Why?
Pancreatic Diseases
1
2019
66
0.140
 Why?
Neutrophils
1
2024
1124
0.140
 Why?
Registries
2
2021
2406
0.140
 Why?
Skin Pigmentation
1
2019
48
0.140
 Why?
Phenotype
2
2026
3155
0.130
 Why?
Referral and Consultation
1
2024
867
0.130
 Why?
Appendiceal Neoplasms
1
2017
28
0.130
 Why?
Tomography, X-Ray Computed
3
2025
2769
0.130
 Why?
Population Surveillance
1
2021
484
0.130
 Why?
Anesthesia
1
2021
256
0.130
 Why?
Common Bile Duct Neoplasms
1
2017
28
0.130
 Why?
Patient Acceptance of Health Care
1
2024
881
0.130
 Why?
Patient Compliance
1
2021
587
0.130
 Why?
Pylorus
1
2017
17
0.130
 Why?
Gastric Outlet Obstruction
1
2017
12
0.130
 Why?
Carcinoma, Renal Cell
2
2026
230
0.120
 Why?
Carcinoma, Ductal, Breast
1
2017
89
0.120
 Why?
Waiting Lists
2
2009
266
0.120
 Why?
Radiotherapy, Intensity-Modulated
1
2018
142
0.120
 Why?
Disease Management
1
2021
653
0.120
 Why?
Analgesics, Opioid
1
2025
1149
0.120
 Why?
Hospitals, High-Volume
1
2016
50
0.120
 Why?
Nutritional Status
1
2019
353
0.120
 Why?
Cancer Care Facilities
1
2016
48
0.120
 Why?
Neoplasms
2
2022
2906
0.120
 Why?
Neuromuscular Agents
1
2017
46
0.120
 Why?
Hospitals
1
2021
732
0.120
 Why?
Botulinum Toxins, Type A
1
2017
59
0.120
 Why?
Genital Neoplasms, Female
1
2017
99
0.120
 Why?
Obesity
2
2025
3116
0.120
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1963
0.120
 Why?
Tomography, Emission-Computed, Single-Photon
1
2016
104
0.110
 Why?
Cannabis
1
2023
509
0.110
 Why?
Platelet Count
2
2025
94
0.110
 Why?
Patient Reported Outcome Measures
1
2019
497
0.110
 Why?
Adenoma
1
2017
218
0.110
 Why?
Kidney Neoplasms
2
2026
413
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
1189
0.110
 Why?
Delivery of Health Care
1
2021
946
0.100
 Why?
Radiosurgery
1
2018
399
0.100
 Why?
Patient Readmission
1
2019
769
0.100
 Why?
Morbidity
4
2021
322
0.100
 Why?
Antineoplastic Agents
3
2021
2214
0.100
 Why?
Unnecessary Procedures
1
2014
54
0.100
 Why?
Hospital Mortality
4
2024
1038
0.100
 Why?
Anti-Bacterial Agents
1
2004
1923
0.100
 Why?
Trauma Centers
2
2014
466
0.100
 Why?
Abdomen
1
2013
142
0.090
 Why?
Radiation Dosage
1
2014
193
0.090
 Why?
Preoperative Period
2
2025
149
0.090
 Why?
Renal Insufficiency
1
2013
172
0.090
 Why?
Pandemics
3
2025
1707
0.080
 Why?
Clinical Competence
1
2019
1243
0.080
 Why?
Severity of Illness Index
3
2025
2930
0.080
 Why?
Asia
2
2021
70
0.080
 Why?
Triage
1
2012
250
0.080
 Why?
Logistic Models
2
2025
2134
0.070
 Why?
Europe
2
2021
418
0.070
 Why?
Organ Preservation Solutions
2
2006
46
0.070
 Why?
Kidney Transplantation
2
2013
712
0.070
 Why?
Graft Survival
2
2009
518
0.070
 Why?
Diagnostic Tests, Routine
2
2024
107
0.070
 Why?
Brain Injuries
1
2014
507
0.070
 Why?
Practice Patterns, Physicians'
1
2017
1371
0.070
 Why?
Bile Ducts, Extrahepatic
1
2008
20
0.070
 Why?
Laparotomy
1
2008
113
0.070
 Why?
Biliary Tract Surgical Procedures
1
2008
28
0.070
 Why?
Case-Control Studies
2
2007
3623
0.060
 Why?
Cholangitis, Sclerosing
1
2008
61
0.060
 Why?
Electrocoagulation
1
2007
35
0.060
 Why?
Anus Neoplasms
1
2007
32
0.060
 Why?
Intraoperative Care
1
2007
63
0.060
 Why?
Congenital Hypothyroidism
1
1986
10
0.060
 Why?
Brazil
2
2008
179
0.060
 Why?
Multivariate Analysis
2
2025
1547
0.060
 Why?
Young Adult
7
2022
14219
0.060
 Why?
Guideline Adherence
2
2024
586
0.060
 Why?
Retroperitoneal Neoplasms
1
2026
28
0.060
 Why?
Vascular Patency
1
2026
121
0.060
 Why?
Fluorouracil
2
2022
231
0.060
 Why?
Ultrasonography, Interventional
1
2007
165
0.060
 Why?
Mycophenolic Acid
1
2006
120
0.060
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
30
0.050
 Why?
Sample Size
1
2025
121
0.050
 Why?
Lymphocyte Count
1
2024
164
0.050
 Why?
Adolescent
9
2022
22530
0.050
 Why?
Wounds and Injuries
1
2012
961
0.050
 Why?
Zygomycosis
1
2003
6
0.050
 Why?
Radiotherapy, Adjuvant
2
2019
222
0.050
 Why?
Bile Ducts, Intrahepatic
1
2024
63
0.050
 Why?
Developmental Disabilities
1
1986
281
0.050
 Why?
Sarcoma
1
2026
207
0.050
 Why?
Cross-Sectional Studies
3
2026
5905
0.050
 Why?
Cluster Analysis
1
2025
500
0.050
 Why?
Comorbidity
2
2022
1661
0.050
 Why?
Hepatocytes
1
2004
224
0.050
 Why?
Antibiotic Prophylaxis
1
2004
134
0.050
 Why?
Gastrectomy
1
2024
166
0.050
 Why?
Biology
1
2023
88
0.050
 Why?
Capecitabine
1
2022
56
0.040
 Why?
Appendicitis
1
2004
150
0.040
 Why?
Carcinoma, Squamous Cell
1
2007
641
0.040
 Why?
Pneumonectomy
1
2023
167
0.040
 Why?
Anesthesia, Intravenous
1
2021
24
0.040
 Why?
Anesthetics, Intravenous
1
2021
69
0.040
 Why?
Esophagogastric Junction
1
2021
55
0.040
 Why?
Models, Biological
1
2008
1764
0.040
 Why?
Induction Chemotherapy
1
2021
88
0.040
 Why?
Surgical Wound Infection
1
2004
329
0.040
 Why?
Thoracoscopy
1
2020
60
0.040
 Why?
Liver
2
2006
1896
0.040
 Why?
Image-Guided Biopsy
1
2019
41
0.040
 Why?
Medical Oncology
1
2022
339
0.040
 Why?
Adenocarcinoma, Mucinous
1
2020
76
0.040
 Why?
Societies, Medical
1
2024
899
0.040
 Why?
Perioperative Period
1
2017
70
0.030
 Why?
Oxidative Stress
1
2004
1356
0.030
 Why?
Reproducibility of Results
1
2025
3413
0.030
 Why?
Occipital Bone
1
2017
18
0.030
 Why?
Parotid Gland
1
2017
17
0.030
 Why?
Carcinoma, Lobular
1
2017
56
0.030
 Why?
Gastric Emptying
1
2017
36
0.030
 Why?
Health Behavior
1
2002
789
0.030
 Why?
Neck
1
2017
108
0.030
 Why?
Longitudinal Studies
1
2024
2953
0.030
 Why?
Sex Factors
1
2022
2105
0.030
 Why?
Raffinose
2
2006
29
0.030
 Why?
Consensus
1
2017
477
0.030
 Why?
Perioperative Care
1
2018
231
0.030
 Why?
Allopurinol
2
2006
70
0.030
 Why?
Glucose
1
2020
1048
0.030
 Why?
Drug Administration Schedule
1
2015
782
0.020
 Why?
Adenosine
2
2006
255
0.020
 Why?
Glutathione
2
2006
370
0.020
 Why?
Glasgow Coma Scale
1
2014
218
0.020
 Why?
Vital Signs
1
2012
46
0.020
 Why?
Radiation Injuries
1
2014
149
0.020
 Why?
New South Wales
1
2012
22
0.020
 Why?
Incidence
1
2019
2923
0.020
 Why?
Baltimore
1
2012
72
0.020
 Why?
Italy
1
2012
116
0.020
 Why?
Magnetic Resonance Imaging
1
2025
3904
0.020
 Why?
Disease Progression
1
2020
2864
0.020
 Why?
Child
6
2014
22707
0.020
 Why?
Hospital Costs
1
2012
125
0.020
 Why?
Pharmaceutical Preparations
1
2013
170
0.020
 Why?
Biological Therapy
1
2011
28
0.020
 Why?
Child, Preschool
4
2014
11853
0.020
 Why?
Albuminuria
1
1992
189
0.020
 Why?
Chi-Square Distribution
1
2012
527
0.020
 Why?
Injury Severity Score
1
2012
599
0.020
 Why?
Lung
1
2023
4106
0.020
 Why?
Glomerular Filtration Rate
1
2013
765
0.020
 Why?
Surveys and Questionnaires
1
2022
6066
0.020
 Why?
Carcinoembryonic Antigen
1
2008
40
0.020
 Why?
Immunosuppressive Agents
1
2013
838
0.020
 Why?
Infant, Newborn
2
2014
6447
0.020
 Why?
Antimetabolites, Antineoplastic
1
2008
106
0.020
 Why?
Sensitivity and Specificity
1
2012
1997
0.020
 Why?
Fluorodeoxyglucose F18
1
2008
161
0.020
 Why?
Radiopharmaceuticals
1
2008
205
0.020
 Why?
Infant
3
2014
10077
0.020
 Why?
Retreatment
1
2007
79
0.020
 Why?
Colorado
1
2017
4554
0.020
 Why?
Cholecystectomy
1
2007
61
0.020
 Why?
Incidental Findings
1
2007
81
0.020
 Why?
Positron-Emission Tomography
1
2008
343
0.020
 Why?
Neoplasm, Residual
1
2007
143
0.020
 Why?
Biopsy, Needle
1
2007
185
0.020
 Why?
Tablets, Enteric-Coated
1
2006
5
0.020
 Why?
Hepatitis B
1
2007
66
0.010
 Why?
Histidine
1
2006
66
0.010
 Why?
Radiography
1
2008
852
0.010
 Why?
Psychological Tests
1
1986
130
0.010
 Why?
Graft Rejection
1
2009
521
0.010
 Why?
Overweight
1
2010
614
0.010
 Why?
Tryptophan
1
2006
182
0.010
 Why?
Glutathione Disulfide
1
2004
30
0.010
 Why?
Insulin
2
2006
2512
0.010
 Why?
Hepatitis C
1
2007
256
0.010
 Why?
Sulfamethoxypyridazine
1
1983
1
0.010
 Why?
Trimethoprim
1
1983
7
0.010
 Why?
Liver Function Tests
1
2004
105
0.010
 Why?
Anti-Infective Agents, Urinary
1
1983
16
0.010
 Why?
Amphotericin B
1
2003
36
0.010
 Why?
Gastrointestinal Diseases
1
2006
221
0.010
 Why?
Liver Diseases
1
2006
305
0.010
 Why?
Antifungal Agents
1
2003
151
0.010
 Why?
Immunocompromised Host
1
2003
202
0.010
 Why?
Cause of Death
1
2004
470
0.010
 Why?
Reperfusion Injury
1
2004
293
0.010
 Why?
Urinary Tract Infections
1
1983
210
0.010
 Why?
Cardiovascular Diseases
1
1992
2187
0.010
 Why?
Diabetes Mellitus, Type 1
1
1992
3922
0.010
 Why?
Cholesterol
1
1992
408
0.000
 Why?
Blood Pressure
1
1992
1779
0.000
 Why?
Sulfamethoxazole
1
1983
7
0.000
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1983
43
0.000
 Why?
Escherichia coli Infections
1
1983
125
0.000
 Why?
Drug Combinations
1
1983
396
0.000
 Why?
Microbial Sensitivity Tests
1
1983
364
0.000
 Why?
Escherichia coli
1
1983
835
0.000
 Why?
Clinical Trials as Topic
1
1983
1061
0.000
 Why?
Gleisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (344) concept(s)
_
Co-Authors Expand Description
See all (55) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)